J. Möschwitzer

Pharmaceutical Science · 2013

A researcher in the Science corpus: 2 papers; trusts 8 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom J. Möschwitzer trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. R. Müller
  2. E. Merisko-Liversidge
  3. B. Rabinow
  4. Colin W. Pouton
  5. J. Breitenbach
  6. G. Liversidge
  7. M. Brewster
  8. C. Keck
  9. R. Shegokar

Papers from J. Möschwitzer's perspective

Ordered by how strongly the researchers J. Möschwitzer trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use. (Angewandte Chemie)
  2. Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. (Advanced Drug Delivery Reviews)
  3. What is the True Solubility Advantage for Amorphous Pharmaceuticals? (Pharmaceutical Research)
  4. Solid lipid nanoparticles: production, characterization and applications. (Advanced Drug Delivery Reviews)
  5. Drug-like properties and the causes of poor solubility and poor permeability. (Journal of pharmacological and toxicological methods)
  6. A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes. (European journal of pharmaceutics and biopharmaceutics)
  7. Evaluation of cyclodextrin solubilization of drugs. (International journal of pharmaceutics)
  8. Solubilizing Excipients in Oral and Injectable Formulations (Pharmaceutical Research)
  9. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. (International journal of pharmaceutics)
  10. Cyclodextrin-based pharmaceutics: past, present and future (Nature reviews. Drug discovery)

Their papers